16/05/2024  17:30:31 Chg. -0.70 Volume Bid19:54:00 Demandez à19:54:00 Capitalisation boursière Dividende Y. Rapport P/E
296.80CHF -0.24% 188,184
Chiffrre d'affaires: 55.88 Mio.
296.80Bid taille: 12 -Ask la taille: 51 17.7 Mrd.CHF 1.45% 29.44

Description de l'entreprise

Sonova, headquartered in Stäfa, Switzerland, is the leading manufacturer of innovative hearing care solutions. The Group operates through its core business brands Phonak, Unitron, Advanced Bionics and Connect Hearing. Sonova offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants to wireless communication solutions. Founded in 1947, the Group is currently present in over 100 countries across the globe. Across all businesses, and by supporting the Hear the World Foundation, Sonova pursues its vision of a world where everyone enjoys the delight of hearing and therefore lives a life without limitations.
 

Conseil d'administration & Conseil de surveillance

PDG
Arnd Kaldowski
Conseil d'administration
Birgit Conix, Claudio Bartesaghi, Ludger Althoff, Robert Woolley, Lilika Beck, Oliver Lux
Conseil de surveillance
Robert F. Spoerry, Adrian Widmer, Greg Behar, Jinlong Wang, Lukas Braunschweiler, Lynn Dorsey Bleil, Roland Diggelmann, Ronald van der Vis, Stacy Enxing Seng, Julie Tay
 

Données de l'entreprise

Nom: Sonova Holding AG
Adresse: Laubisrütistraße 28,CH-8712 Stäfa
Téléphone: +41-58-928-0101
Fax: +41-58-928-2011
Courriel: info@sonova.com
Internet: www.sonova.com
Industrie: Healthcare
Secteur: Healthcare Providers
Sous-secteur: Healthcare Providers
Fin de l'exercice financier: 31/03
Flotte libre: 79.40%
IPO date: 01/11/1994

Relations avec les investisseurs

Nom: Thomas Bernhardsgrütter
Téléphone IR: +41-58-928-3344
IR-Fax: +41 (58) 928 3399
E-mail IR: ir@sonova.com

Calendrier de l'entreprise

CW 24 | 11/06/2024 General Shareholder Meeting
CW 24 | 12/06/2024 Ex-Dividend
CW 24 | 13/06/2024 Record Date
CW 25 | 18/06/2024 Dividend Payment
CW 47 | 19/11/2024 Interim Report 2nd Quarter/6 Months
 

Principaux actionnaires

Autres
 
71.38%
Beda Diethelm and Annamaria Diethelm-Pandiani
 
11.26%
Family of Hans-Ueli Rihs
 
6.18%
BlackRock, Inc.
 
5.10%
UBS Fund Management AG
 
3.06%
MFS Investment Management
 
3.02%